Compared with nondeleted littermate controls (WT-PyMT), deletion of Lats2 significantly augmented mammary tumor burden (Fig 2A), formally validating the tumor suppressive function of LATS2 in mammary tumors. The gene discussed is LATS2; the disease is breast cancer.